Matrix Essentials
This article was originally published in The Rose Sheet
Executive Summary
Bristol-Myers Squibb subsidiary appoints Michael DeGennaro president, succeeding Sydell Miller, who will continue to hold the position of chairman. DeGennaro was formerly VP for corporate development at Bristol-Myers Squibb. BMS acquired Matrix June 16 ("The Rose Sheet" June 20, p. 1)